Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic medication. It acts as a peripheral antimuscarinic agent, primarily affecting the smooth muscle of the gastrointestinal tract. It is NOT a centrally acting anticholinergic like scopolamine (hyoscine hydrobromide).
## Primary Indications
* Symptomatic relief of abdominal cramps and pain associated with gastrointestinal disorders, such as irritable bowel syndrome (IBS) and diverticular disease.
* Pre-procedural bowel preparation (e.g., for colonoscopy or barium enema).
## Adult Dosing
* **Oral:** 10-20 mg three to five times daily.
* **Injection (IM/IV):** 20 mg as a single dose. May be repeated every 4-8 hours if necessary. Maximum daily dose for injection is typically 100 mg.
## Pediatric Dosing
* **Oral:** Dosing is not well-established. Some sources suggest 5-10 mg two to three times daily for children aged 6-12 years, but use with caution and under medical supervision.
* **Injection:** Dosing is not well-established in pediatric populations. Use in children is generally discouraged due to potential for adverse effects and lack of robust data.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific dose adjustments are routinely recommended, but caution is advised, especially in severe impairment, due to potential for increased systemic exposure.
## Contraindications
* Myasthenia gravis.
* Gastrointestinal obstruction or ileus.
* Megacolon.
* Glaucoma (specifically narrow-angle glaucoma).
* Tachyarrhythmias.
* Known hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Prostatic hypertrophy with urinary retention.
## Adverse Effects
Common adverse effects include dry mouth, blurred vision, pupil dilation (mydriasis), urinary retention, constipation, and increased heart rate (tachycardia). Less common effects can include dizziness, drowsiness, and skin rash.
## Key Drug Interactions
* **Anticholinergic Agents:** Additive effects with other anticholinergic drugs (e.g., tricyclic antidepressants, antihistamines, some antipsychotics) can increase the risk of side effects like dry mouth, constipation, urinary retention, and CNS effects.
* **Dopamine Agonists (e.g., Metoclopramide):** Hyoscine butylbromide may antagonize the prokinetic effects of dopamine agonists.
* **Beta-agonists:** May reduce the bronchodilator effects of beta-agonists.
## Monitoring
* Monitor for signs of anticholinergic adverse effects (e.g., dry mouth, blurred vision, urinary hesitancy, constipation).
* Assess for relief of abdominal symptoms.
* In patients with glaucoma, monitor intraocular pressure if concerns arise.
## Clinical Pearls
* Hyoscine butylbromide is a peripheral antispasmodic and does not typically cross the blood-brain barrier, hence fewer central nervous system effects compared to scopolamine.
* Oral formulations have a slower onset of action compared to parenteral administration.
* Injection should be administered slowly to minimize potential side effects.
* Ensure adequate hydration and stool softeners if constipation is a prominent or persistent adverse effect.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines for definitive patient management. Local protocols may dictate specific dosing or utilization.
